Oscar Health (OSCR) Could Be 95% Undervalued After Raising 2026 Guidance Again
Oscar Health (OSCR) just flipped its story. Fresh third quarter results showed revenue of US$5.14b and net income of US$167.28m, and management raised full year 2026 guidance again.
The share price reaction told a mixed story. Oscar Health closed at US$30.65 after falling 7.6% on the day. However, it still carries a 104.7% year to date share price return and a 331% three year total shareholder return. This points to strong momentum that is now being tested as investors reassess how much of the earnings turnaround and guidance upgrades are already reflected in the valuation.
Scan how Oscar Health compares with other insurers that also show strong membership trends and profitability turnarounds using our curated list of 31 resilient stocks with low risk scores.
Oscar Health now pairs a sharp profit turnaround with a stock that has doubled this year and just sold off. Does the current price still leave enough potential reward for the risk you take on?
Most Popular Narrative: 95% Undervalued
Against a last close of $30.65, the leading narrative on Oscar Health points to a fair value of $583.34, which implies a very large gap between the trading price and that estimate.
Every so often, a ticker flashes on my screen that makes me stop and rub my eyes. It is the kind of number that look like a mistake, like you thought you were getting clothes on Christmas Day, but then your parents surprise you by hiding the PlayStation 2 you've been wanting for months in the other room...
The screen showed Oscar Health. Ridiculous name for a health insurance company, but the numbers are anything but.
See why 12 investors see Oscar Health as 95% undervalued.
According to J_Tyrader, the narrative leans heavily on a discounted cash flow model that points to a fair value of $583.34 per share, compared with the recent $30.65 trading level. It frames that gap as a very large implied discount driven by cash generation, high reported returns on capital and a sizable net cash position.
Result: Fair Value of $583.34 (UNDERVALUED)
Still, the story breaks quickly if Oscar Health falls short of the heavy growth and margin assumptions in that DCF, or if cash conversion weakens materially.
Find out about the key risks to this Oscar Health narrative.
Next Steps
Sentiment around Oscar Health is divided, with clear risks on one side and genuine upside on the other. Move quickly, stress test those views against the underlying numbers, and then weigh the 4 key rewards and 2 important warning signs
Looking for more Oscar Health investment ideas?
If you only focus on Oscar Health, you could miss other compelling setups that fit your risk profile and return goals across different sectors and company sizes.
- Chase asymmetric upside by reviewing a hand picked group of 9 elite penny stocks with strong financials that pair tiny market values with stronger balance sheets and fundamentals than many expect.
- Stack the odds in your favor by scanning a curated pool of 19 high quality undiscovered gems that combine robust financials with quieter market attention.
- Prioritize resilience first by filtering for a list of solid balance sheet and fundamentals (25 results) that can handle shocks while still giving you room for future upside.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com